Patient Preference and Adherence
Volume 14, 2020 - Issue
Open access
173
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Experiment and Best–Worst Scaling
Martine C Maculaitis1 Kantar, Health Division, New York, NY, USACorrespondence[email protected]
View further author information
, View further author information
Xianchen Liu2 Pfizer Oncology, Pfizer Inc, New York, NY, USAhttps://orcid.org/0000-0002-4325-2545View further author information
, Oliver Will3 Kantar, Health Division, Horsham, PA, USAView further author information
, Madelyn Hanson4 Kantar, Health Division, St. Louis, MO, USAView further author information
, Lynn McRoy2 Pfizer Oncology, Pfizer Inc, New York, NY, USAView further author information
, Alexandra Berk1 Kantar, Health Division, New York, NY, USAView further author information
& Melissa Crastnopol3 Kantar, Health Division, Horsham, PA, USAView further author information
show all
Pages 2201-2214
|
Published online: 05 Nov 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.